secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001493152-26-000175
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs receives Nasdaq delisting notice for bid-price non-compliance; trading to suspend Jan 5
--------------------------------------------------------------------------------

- Nasdaq staff determination on Dec 29, 2025: company failed to regain compliance with minimum $1.00 bid price rule after two 180-day periods ending Dec 22.
- Common stock trading will be suspended at the open on Jan 5, 2026; Nasdaq will file Form 25 to remove the listing.
- Company intends to timely request a hearing before Nasdaq Hearings Panel to appeal the staff determination.
- Concurrently, ProPhase is applying for quotation of its common stock on the OTC Markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000149315226000175/0001493152-26-000175-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000149315226000175/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000175

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer